New Horizons In Type 2 Diabetes Research

  • Playlist
  • Download
  • Embed
    Embed <iframe src="http://www.npr.org/player/embed/96739446/96747176" width="100%" height="290" frameborder="0" scrolling="no">
  • Transcript

Two papers published in the journal Cell Metabolism present different approaches to controlling glucose levels in people with Type 2 diabetes — the form of the disease in which the body gradually loses the ability to use insulin to control sugar levels in the blood.

In one, a hormone called apelin, which is produced in fat tissues, was injected intravenously into normal and obese mice, and was found to significantly reduce blood sugar levels.

In another study, researchers used an experimental drug manufactured by GlaxoSmithKline that mimics the behavior of resveratrol, a compound found in red wine and grapes. The artificial resveratrol decreased blood sugar levels and restored insulin levels to normal in diabetic mice.

C. Ronald Kahn, professor at the Harvard Medical School, talks about the two approaches and other work on treating diabetes.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.